Neuroone Medical Technologies (NMTC) Net Margin (2010 - 2026)

Neuroone Medical Technologies' Net Margin history runs 13 years deep, the most recent figure standing at 127.92% for Q1 2026.

• Quarterly Net Margin rose 3583.0% year-over-year to 127.92% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 75.5% (up 3916.0% YoY) and the FY2025 annual result came in at 39.63%, up 31711.0% from the prior year.
• Net Margin was 127.92% for Q1 2026 at Neuroone Medical Technologies, down from 49.71% in the prior quarter.
• Across five years, Net Margin topped out at 54.53% in Q4 2024 and bottomed at 8610.96% in Q2 2022.
• A 5-year average of 1456.4% and a median of 342.14% in 2023 frame the typical range for Net Margin.
• Peak annual rise in Net Margin reached 2169548 bps in 2022, while the deepest fall reached 124961 bps in 2022.
• Neuroone Medical Technologies' Net Margin stood at 1512.29% in 2022, then jumped by 77 bps to 342.14% in 2023, then soared by 116 bps to 54.53% in 2024, then plunged by 191 bps to 49.71% in 2025, then plunged by 157 bps to 127.92% in 2026.
• Business Quant data shows NMTC's Net Margin at 127.92% in Q1 2026, 49.71% in Q4 2025, and 59.08% in Q3 2025.